Citation:Kerr RS, Love S, Segelov E, Johnstone E, Falcon B, Hewett P, et al 2016

Citation

Kerr RS, Love S, Segelov E, Johnstone E, Falcon B, Hewett P, et al. Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. Lancet Oncol 2016 Nov;17(11):1543-1557 Available from: http://www.ncbi.nlm.nih.gov/pubmed/27660192.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Adjuvant therapy for stage III colon cancer
2. Irinotecan and targeted (biological) agents in adjuvant therapy for stage II and stage III colon cancer